Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2013-09-01 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HOLTZHEIM (67810), Bas-Rhin
SELURL PHARMACIE DE HOLTZHEIM : revenue, balance sheet and financial ratios
SELURL PHARMACIE DE HOLTZHEIM is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HOLTZHEIM (67810),
this company of category PME
shows in 2022 a revenue of 3.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE DE HOLTZHEIM (SIREN 795195577)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
3 420 012 €
N/C
3 042 197 €
2 855 968 €
N/C
N/C
2 916 454 €
Net income
176 587 €
186 991 €
193 960 €
121 149 €
127 117 €
93 696 €
130 807 €
97 911 €
EBITDA
N/C
291 127 €
N/C
249 110 €
247 710 €
N/C
N/C
223 510 €
Net margin
N/C
5.5%
N/C
4.0%
4.5%
N/C
N/C
3.4%
Revenue and income statement
In 2023, SELURL PHARMACIE DE HOLTZHEIM generates positive net income of 177 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 98 k€ -> 177 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
176 587 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 111%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
110.637%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.297%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELURL PHARMACIE DE HOLTZHEIM
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
489.823
458.112
359.806
285.062
232.967
174.584
139.817
110.637
Financial autonomy
14.781
15.598
18.704
22.847
26.134
31.182
36.247
41.297
Repayment capacity
20.968
None
None
14.862
15.475
None
8.759
None
Cash flow / Revenue
3.762%
None%
None%
4.715%
4.163%
None%
5.693%
None%
Sector positioning
Debt ratio
110.642023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-7 pts over 3 years
In 2023, the debt ratio of SELURL PHARMACIE DE HOLTZ... (110.64) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.3%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+9 pts over 3 years
In 2023, the financial autonomy of SELURL PHARMACIE DE HOLTZ... (41.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
8.76 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELURL PHARMACIE DE HOLTZ... (8.76) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 132.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
132.824
Liquidity indicators evolution SELURL PHARMACIE DE HOLTZHEIM
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
93.137
102.038
87.943
91.818
111.604
120.091
129.501
132.824
Interest coverage
33.3
None
None
21.897
17.718
None
10.354
None
Sector positioning
Liquidity ratio
132.822023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch
In 2023, the liquidity ratio of SELURL PHARMACIE DE HOLTZ... (132.82) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
10.35x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of SELURL PHARMACIE DE HOLTZ... (10.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELURL PHARMACIE DE HOLTZHEIM
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Operating WCR
283 217 €
0 €
0 €
320 468 €
322 808 €
0 €
361 837 €
0 €
Inventory turnover (days)
35
0
0
40
39
0
35
0
Customer payment term (days)
6
0
0
5
4
0
5
0
Supplier payment term (days)
51
0
0
49
51
0
50
0
Positioning of SELURL PHARMACIE DE HOLTZHEIM in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELURL PHARMACIE DE HOLTZHEIM is estimated at
2 083 634 €
(range 1 267 157€ - 2 929 121€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1267k€2083k€2929k€
2 083 634 €Range: 1 267 157€ - 2 929 121€
NAF 5 année 2023
Valuation method used
Net Income Multiple
176 587 €
×
11.8x
=2 083 634 €
Range: 1 267 158€ - 2 929 122€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE DE HOLTZHEIM with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE DE HOLTZHEIM
What is the revenue of SELURL PHARMACIE DE HOLTZHEIM ?
The revenue of SELURL PHARMACIE DE HOLTZHEIM in 2022 is 3.4 M€.
Is SELURL PHARMACIE DE HOLTZHEIM profitable?
Yes, SELURL PHARMACIE DE HOLTZHEIM generated a net profit of 177 k€ in 2023.
Where is the headquarters of SELURL PHARMACIE DE HOLTZHEIM ?
The headquarters of SELURL PHARMACIE DE HOLTZHEIM is located in HOLTZHEIM (67810), in the department Bas-Rhin.
Where to find the tax return of SELURL PHARMACIE DE HOLTZHEIM ?
The tax return of SELURL PHARMACIE DE HOLTZHEIM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE DE HOLTZHEIM operate?
SELURL PHARMACIE DE HOLTZHEIM operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart